Instant Healthcare Diagnostics.
Toku Eyes developed a multi-modal artificial intelligence platform for instant healthcare diagnostics, personalised prognostics and general health risk assessments using retinal images to screen for preventable blindness and cardiovascular disease risk.
of blindness from diabetic retinopathy can be avoided with early, accurate and accessible diagnosis (1)
of the population should be monitored for diabetes, hypertension and macular degeneration
of cardiac events are preventable (2)
screening capacity increase (3)
reduction in cost of screening (3)
Click to View References & Sources
Designed for People Living with Diabetes
People with diabetes and prediabetes are at severe risk of vision loss and heart disease
- 2 x more likely to develop cardiovascular disease (4)
- 1 in 3 have diabetic retinopathy, which if left untreated will lead to permanent vision loss (5)
Toku Eyes has developed a better way to screen for these comorbidities of diabetes by using AI
The health assessment is powered by two AI platforms:
- CLAiR which assesses cardiovascular risk
- THEIA which identifies indications of eye diseases such as diabetic retinopathy and maculopathy
Click to View References & Sources
Our
Vision
If you can see the future, you can change it
- Over 80% of cardiac events and diabetes related blindness is preventable by identifying risk and applying targeted interventions (6)
- Toku Eyes provides the earliest possible indication of diseases and root causes compared to a non AI-assisted trained eye specialist
- Utilising individualised, patient-specific prognostics
- Developing accurate screening, diagnosis recommendations and severity grading within 60 seconds
- Expanding the capabilities and accessibility of current eye imaging technologies into diabetes and cardiovascular diseases
Click to View References & Sources
Meet THEIA™
Our products are not available in all jurisdictions, contact us today to find out if we are available in your market.
Meet CLAiR™
Our products are not available in all jurisdictions, contact us today to find out if we are available in your market.